{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:16:20Z","timestamp":1778084180048,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"DOI":"10.7759\/cureus.108368","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:43:10Z","timestamp":1778082190000},"source":"Crossref","is-referenced-by-count":0,"title":["Excessive Sedation and Catatonia-Like Presentation From Risperidone-Valproate Interaction: A Case Report"],"prefix":"10.7759","author":[{"given":"Da Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Canova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebria","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica V","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia M","family":"Canova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukhsar","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Risperdal Consta\u00ae (risperidone) long-acting injection \u2014 prescribing information. (2024). Accessed. December 10, 2025: https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/RISPERDAL%20CONSTA-pi.pdf."},{"key":"ref2","article-title":"Risperidone","author":"McNeil SE","year":"2026","unstructured":"McNeil SE, Gibbons JR, Cogburn M. Risperidone. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx157","article-title":"Prevalence of catatonia and its moderators in clinical samples: results from a meta-analysis and meta-regression analysis","volume":"44","author":"Solmi M","year":"2018","unstructured":"Solmi M, Pigato GG, Roiter B, et al.. Prevalence of catatonia and its moderators in clinical samples: results from a meta-analysis and meta-regression analysis. Schizophr Bull. 2018, 44:1133-50. 10.1093\/schbul\/sbx157","journal-title":"Schizophr Bull"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00534-w","article-title":"Catatonia","volume":"10","author":"Hirjak D","year":"2024","unstructured":"Hirjak D, Rogers JP, Wolf RC, et al.. Catatonia. Nat Rev Dis Primers. 2024, 10:49. 10.1038\/s41572-024-00534-w","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2007.19.4.406","article-title":"Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes","volume":"19","author":"Carroll BT","year":"2007","unstructured":"Carroll BT, Goforth HW, Thomas C, et al.. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci. 2007, 19:406-12. 10.1176\/jnp.2007.19.4.406","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca E","year":"2002","unstructured":"Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002, 16:695-714. 10.2165\/00023210-200216100-00004","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert P","year":"2014","unstructured":"Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014, 5:181. 10.3389\/fpsyt.2014.00181","journal-title":"Front Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers JP","year":"2023","unstructured":"Rogers JP, Oldham MA, Fricchione G, et al.. Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023, 37:327-69. 10.1177\/02698811231158232","journal-title":"J Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2434","article-title":"CYP2D6 genetic polymorphisms and risperidone pharmacokinetics: a systematic review and meta-analysis","volume":"40","author":"Zhang L","year":"2020","unstructured":"Zhang L, Brown SJ, Shan Y, et al.. CYP2D6 genetic polymorphisms and risperidone pharmacokinetics: a systematic review and meta-analysis. Pharmacotherapy. 2020, 40:632-47. 10.1002\/phar.2434","journal-title":"Pharmacotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200301000-00001","article-title":"Valproic acid and risperidone: a drug interaction?","volume":"42","author":"Sund JK","year":"2003","unstructured":"Sund JK, Aamo T, Spigset O. Valproic acid and risperidone: a drug interaction?. J Am Acad Child Adolesc Psychiatry. 2003, 42:1-2. 10.1097\/00004583-200301000-00001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X20666220524121645","article-title":"Pharmacokinetic interactions between antiseizure and psychiatric medications","volume":"21","author":"Zaccara G","year":"2023","unstructured":"Zaccara G, Franco V. Pharmacokinetic interactions between antiseizure and psychiatric medications. Curr Neuropharmacol. 2023, 21:1666-90. 10.2174\/1570159X20666220524121645","journal-title":"Curr Neuropharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328348c76b","article-title":"Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants","volume":"21","author":"Erickson-Ridout KK","year":"2011","unstructured":"Erickson-Ridout KK, Zhu J, Lazarus P. Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants. Pharmacogenet Genomics. 2011, 21:539-51. 10.1097\/FPC.0b013e328348c76b","journal-title":"Pharmacogenet Genomics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.120","article-title":"Pharmacogenetics of olanzapine metabolism","volume":"14","author":"S\u00f6derberg MM","year":"2013","unstructured":"S\u00f6derberg MM, Dahl ML. Pharmacogenetics of olanzapine metabolism. Pharmacogenomics. 2013, 14:1319-36. 10.2217\/pgs.13.120","journal-title":"Pharmacogenomics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.5.765","article-title":"A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder","volume":"158","author":"Conley RR","year":"2001","unstructured":"Conley RR, Mahmoud R. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2001, 158:765-74. 10.1176\/appi.ajp.158.5.765","journal-title":"Am J Psychiatry"},{"key":"ref15","article-title":"Catatonia","author":"Iyer V","year":"2026","unstructured":"Iyer V, Spurling BC, Rizvi A. Catatonia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465064-excessive-sedation-and-catatonia-like-presentation-from-risperidone-valproate-interaction-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:43:15Z","timestamp":1778082195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465064-excessive-sedation-and-catatonia-like-presentation-from-risperidone-valproate-interaction-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.108368","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}